Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-18

Clinical Trial Update: Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of HD-6277 in adults with type 2 diabetes mellitus inadequately controlled by diet and exercise; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HD-6277

Snippet

Sponsor: Hyundai Pharm | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED